Lymphangiomyoma

Subscribe to Selected New Research on Lymphangiomyoma

16 relevant articles (0 outcomes, 0 trials/studies) found for this Disease

Description: A tumorlike condition characterized by SMOOTH MUSCLE and ENDOTHELIUM proliferation of LYMPHATIC VESSELS and LYMPH NODES in the MEDIASTINUM and retroperitoneum, also in the lung. It may be manifested by chylous PLEURAL EFFUSION and ASCITES.

Also Known As:

Lymphangioleiomyomas; Lymphangiomyomas; Lymphangioleiomyoma

Disease Context: Research Results

Neoplasms: 415397

Neoplasms by Histologic Type: 1

Lymphatic Vessel Tumors: 2

Lymphangiomyoma: 16

Lymphangioleiomyomatosis: 429

Hemic and Lymphatic Diseases

Lymphatic Diseases: 1961

Lymphoproliferative Disorders: 2359

Lymphangiomyoma: 16

Lymphangioleiomyomatosis: 429

Immune System Diseases: 1319

Immunoproliferative Disorders: 26

Lymphoproliferative Disorders: 2359

Lymphangiomyoma: 16

Lymphangioleiomyomatosis: 429

Related Diseases

1.	Angiomyolipoma
2.	Lymphangioleiomyomatosis (Lymphangiomyomatosis)
3.	Neoplasms (Cancer)
4.	Perivascular Epithelioid Cell Neoplasms
5.	Pleural Effusion (Pleural Effusions)

Experts

1.	Checrallah, Antoine: 1 article (09/2006)
2.	Chahine, Georges: 1 article (09/2006)
3.	Ghossain, Michel A: 1 article (09/2006)
4.	Atallah, David: 1 article (09/2006)
5.	Rouzier, Roman: 1 article (09/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lymphangiomyoma:

1.	lipoarabinomannan (LAM)IBA 08/20/2009 - "METHODS: Fourteen cases of LAM from Zhongshan Hospital, Fudan University are reviewed, twelve were confirmed by lung biopsy, one by retroperitoneal lymphangioleiomyoma resection, and one by autopsy. " 05/01/2009 - "However, when patient samples were grouped based on the extent of lymphatic extrapulmonary involvement (eg, lymphangioleiomyomas and adenopathy), the statistical difference was maintained only for patients with LAM with lymphatic involvement (p < 0.001), not for those patients whose disease was restricted to the lung. " 05/01/2009 - "It is possible to group the LAM population by the presence or absence of extrapulmonary involvement (eg, AMLs, lymphangioleiomyomas, chylous effusions). " 02/01/2005 - "After a mass is shown in a patient with LAM, repeat sonography in the morning and afternoon is useful to depict diurnal variation in size and echotexture and to confirm the diagnosis of lymphangioleiomyoma and avoid biopsy." 02/01/2005 - "MATERIALS AND METHODS: Forty-four patients with LAM and abdominal and pelvic lymphangioleiomyomas found on screening CT underwent sonography. " Order ALL the reference details at left...
2.	Tamoxifen FDA LinkGeneric 09/01/2006 - "Retroperitoneal lymphangioleiomyoma mimicking ovarian tumor emerging after tamoxifen therapy." Order ALL the reference details at left...
3.	Staphylococcal Protein A (A, Protein)IBA 11/01/1975 - "This report documents a case of cystic lymphangiomyoma of the sigmoid colon in a 35-year-old woman who presented with symptoms of a protein-losing enteropathy. " Order ALL the reference details at left...
4.	HormonesIBA 01/01/2006 - "The second case illustrates the hormone dependent growth of lymphangiomyoma and LAM development in young women. " Order ALL the reference details at left...
5.	Glycoproteins (Glycoprotein)IBA 08/01/1998 - "HMB-45, an antibody directed against a premelanosome glycoprotein, although used predominantly for the diagnosis of MM, has shown consistent staining in angiomyolipoma (AML), lymphangiomyoma/lymphangiomyomatosis (LAM), and clear cell sugar tumor (CCST), a group of tumors proposed to be related on the basis of their common perivascular epithelioid cells, which exhibit various degrees of smooth muscle differentiation, melanogenesis, and intracytoplasmic membrane bound granules. " Order ALL the reference details at left...
6.	Carbon MonoxideIBA 09/01/2000 - "The perivascular epithelioid cell family of tumors (PEComas), defined by their co-expression of melanocytic and muscle markers, includes angiomyolipoma, lymphangioleiomyoma, and clear cell "sugar" tumors of the lung, pancreas, and uterus. " Order ALL the reference details at left...
7.	Anti-Bacterial Agents (Antibiotics)IBA 01/05/2008 - "The acute abdomen and fever appeared to have been caused by a Streptococcus agalactiae infection of the retroperitoneal lymphangiomyoma, which was treated with intravenous antibiotics. " Order ALL the reference details at left...
8.	tebufenozide (Mimic)IBA 07/01/1978 - "There was a mediastinal lymphangiomyoma growing within the distal thoracic duct, and a similar lesion within the left kidney which could clinically mimic an angiomyolipoma. " Order ALL the reference details at left...

Therapies and Procedures

1.	Hysterectomy 10/01/1977 - "A case report is presented of the incidental finding of a lymphangiomyoma in a 50-year-old woman who underwent total hysterectomy for squamous cell carcinoma of the cervix. " 10/01/1995 - "In both, the uterine lesions were grossly inapparent and were discovered during microscopic examination of hysterectomy specimens removed during surgical treatment for a primary ovarian adenocarcinoma with peritoneal and lymph node metastases in one case and a retroperitoneal lymphangiomyoma in the other. " Order ALL the reference details at left...
2.	Nephrectomy 01/01/2007 - "Other findings assessed included noncalcified pulmonary nodules, pleural effusion, thoracic duct dilatation, hepatic and renal angiomyolipomas (AMLs), lymphangioleiomyoma (LALM), ascites, nephrectomy, and renal embolization. " Order ALL the reference details at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>